Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Immun Inflamm Dis ; 10(10): e617, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-36169252

RESUMEN

INTRODUCTION: Evaluation of different cell-based assays for the study of adaptive immune responses against SARS-CoV-2 is crucial for studying long-term and vaccine-induced immunity. METHODS: Enzyme-linked immunospot assay (ELISpot) and intracellular cytokine staining (ICS) using peptide pools spanning the spike protein and nucleoprotein of SARS-CoV-2 were performed in 25 patients who recovered from paucisymptomatic (n = 19) or severe COVID-19 (n = 6). RESULTS: The proportion of paucisymptomatic patients with detectable SARS-CoV-2 T cells was low, as only 44% exhibit a positive T cell response with the ICS and 67% with the ELISpot. The magnitude of SARS-CoV-2 T cell responses was low, both with ICS (median at 0.12% among total T cells) and ELISpot (median at 61 SFCs/million peripheral blood mononuclear cells [PBMC]) assays. Moreover, T cell responses in paucisymptomatic patients seemed lower than among patients with severe disease. In the paucisymptomatic patients, the two assays were well correlated with 76% of concordant responses and a Cohen's kappa of 55. Furthermore, in four patients SARS-CoV-2 T cells were detected by ELISpot but not with ICS. Short-term culture could improve the detection of specific T cells. CONCLUSIONS: In patients who recovered from paucisymptomatic COVID-19, the proportion of detectable anti-SARS-CoV-2 responses and their magnitude seemed lower than in patients with more severe symptoms. The ELISpot appeared to be more sensitive than the ICS assay. Short-term culture revealed that paucisymptomatic patients had nonetheless few SARS-CoV-2 T cells at a very low rate in peripheral blood. These data indicate that various ex-vivo assays may lead to different conclusions about the presence or absence of SARS-CoV-2 T cell immunity.


Asunto(s)
COVID-19 , SARS-CoV-2 , Citocinas , Ensayo de Immunospot Ligado a Enzimas , Citometría de Flujo , Humanos , Leucocitos Mononucleares , Nucleoproteínas , Péptidos , Glicoproteína de la Espiga del Coronavirus , Linfocitos T
2.
Pediatr Nephrol ; 34(7): 1295-1297, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30937552

RESUMEN

BACKGROUND: Iatrogenic induced hypothyroidism had been described in newborns and more particularly in preterm infants after cutaneous or intravenous exposure to iodine. CASE-DIAGNOSIS : We reported a new risk of iodine intoxication with the cases of two newborns who developed hypothyroidism after intra vesical iodine injection during a cystography, which was performed to confirm antenatal diagnosis of posterior urethral valves (PUV). The newborns both developed transient hypothyroidism due to an iodine overdose. CONCLUSIONS: These two observations suggest that voiding cystourethrography (VCUG) should be carefully considered in newborns with severe uropathy, particularly in the case of renal insufficiency. If indicated, thyroid function should be monitored in the following weeks, and in case of hypothyroidism treatment should be started.


Asunto(s)
Medios de Contraste/efectos adversos , Hipotiroidismo/inducido químicamente , Yodo/efectos adversos , Fallo Renal Crónico/complicaciones , Cistografía , Humanos , Recién Nacido , Yopamidol/efectos adversos , Yopamidol/análogos & derivados , Ácido Yotalámico/efectos adversos , Ácido Yotalámico/análogos & derivados , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA